Clinical Evaluation of the TITAN™ Total Shoulder System
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Fracture
- Arthritis
- Arthritis, Degenerative
- Avascular Necrosis
- Dislocation, Shoulder
- Joint Instability
- Joint Trauma
- Pain, Shoulder
- Post-traumatic Arthrosis of Other Joints, Shoulder Region
- Rheumatoid Arthritis
- Rotator Cuff Syndrome of Shoulder and Allied Disorders
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Other
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Observational, multi-center, post-market study to provide data on the performance and safety of the TITAN™ Total Shoulder System. The study will enroll patients that underwent total shoulder arthroplasty with the TITAN™ Total Shoulder System per standard of care less than 5 years ago. Available retr...
Observational, multi-center, post-market study to provide data on the performance and safety of the TITAN™ Total Shoulder System. The study will enroll patients that underwent total shoulder arthroplasty with the TITAN™ Total Shoulder System per standard of care less than 5 years ago. Available retrospective data up to the 2-year time point will be collected, per the study protocol, from medical record reviews. Prospective observational data will be collected from the time of patient enrollment during the following postoperative clinical visits: 1 year, 2 years, 5 years and 10 years post-surgery.
Tracking Information
- NCT #
- NCT03245320
- Collaborators
- Not Provided
- Investigators
- Study Director: Andrew Tummon Integra LifeSciences
Get Well Soon